Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis

Pancreatic enzyme replacement therapy (PERT) is the only treatment for malabsorption in cystic fibrosis (CF) caused by pancreatic insufficiency (PI). PI occurs in approximately 85% of patients with CF. PERT overcomes some, but not all the signs and symptoms of malabsorption. Clinical parameters such...

Descripción completa

Detalles Bibliográficos
Autor principal: Baker, Susan S
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621407/
https://www.ncbi.nlm.nih.gov/pubmed/19209287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621407/
https://www.ncbi.nlm.nih.gov/pubmed/19209287

Ejemplares similares